Contributors
Dr Neil Aaronson |
The Netherlands Cancer Institute, Amsterdam, The Netherlands |
Dr Giovanni Apolone |
Mario Negri Institute, Milano, Italy |
Paulo Carita |
Sanofi-Aventis, Bagneux, France |
Dr Olivier Chassany |
Hôpital St Louis, Paris, France |
Katrin Conway |
Mapi Research Institute & Mapi Research Trust, Lyon, France |
Dr. Dominique Dubois |
Johnson & Johnson Pharmaceutical Services, Beerse, Belgium |
Kirsten Gertsen |
NV Organon, Oss, The Netherlands |
Dr Asha Hareendran |
Pfizer, Sandwich, UK |
Bernard Jambon |
Mapi Group, Lyon, France |
Dr Fred Jost |
F. Hoffman-La Roche Ltd, Basel Switzerland |
Paul Kind |
University of York, UK |
Dr Patrick Marquis |
Mapi Values, Boston, MA, USA |
Dr Pauline McNulty |
Johnson and Johnson, Raritan, NJ, USA |
Dr Carolin Miltenburger |
Schering AG, Berlin, Germany |
Dr Elizabeth Piault |
Mapi Values, Boston, MA, USA |
Dr Margaret Rothman |
Johnson and Johnson, Raritan, NJ, USA |
Dr Pierre-Philippe Sagnier |
Bayer PLC, Uxbridge, UK |
Prof. Marianne Sullivan |
Sahlgrenska University Hospital, Göteborg, Sweden |
Dr. Maria Watson |
GlaxoSmithKline, RTP, NC, USA |
Dr Anders Ingelgard |
AstraZeneca r&D, Moelndal, Sweden |
Dr York Zoellner |
Solvay Pharmaceuticals GmbH, Hannover, Germany |
|